Clinical Analysis of Mifepristone Conservative Treatment with Uterine Myoma
Liming Yu
Abstract
Liming Yu
Abstract
OBJECTIVE To observe the clinical effects of mifepristone conservative treatment with uterine myoma.METHOD From June 2005 to June 2008,46 cases of uterine myoma patients were treated with mifepristone.RESULTS Compared with pre-treatment,the volume of uterine or uterine myoma were significantly deflated(P0.05),resistent index of uterine artery and myoma major blood vessel were significantly increased(P0.05),and the serum FSH,LH,P and E2 after treatment(P0.05).CONCLUSIONS Mifepristone conservatively treated with uterine myoma can deflate uterine volume and decrease serum hormone levels,which is a better medicine.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To observe the clinical effects of mifepristone conservative treatment with uterine myoma.METHOD From June 2005 to June 2008,46 cases of uterine myoma patients were treated with mifepristone.RESULTS Compared with pre-treatment,the volume of uterine or uterine myoma were significantly deflated(P0.05),resistent index of uterine artery and myoma major blood vessel were significantly increased(P0.05),and the serum FSH,LH,P and E2 after treatment(P0.05).CONCLUSIONS Mifepristone conservatively treated with uterine myoma can deflate uterine volume and decrease serum hormone levels,which is a better medicine.
Key concepts: Mifepristone, Medicine, Uterine myoma, Myoma, Conservative treatment, Uterus, Uterine artery, Hormone antagonist